• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT ANTI-HBC II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT ANTI-HBC II Back to Search Results
Catalog Number 08L44-25
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, list number 8l44 that has a similar product distributed in the us, list number 6l22.Patient information: (b)(6) female patient diagnosed with malignant lymphoma.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed (b)(6) architect anti- hbc ii result on (b)(6) year old female patient diagnosed with malignant lymphoma.The results were provided: (b)(6).Previous history from 2012 (b)(6).There was no reported impact to patient management.
 
Manufacturer Narrative
A review of tickets was performed for reagent lot number 07400be00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.A retained reagent kit of lot number 07400be00 was tested in a sensitivity setup, including additional replicates of a sensitivity panel.Results of this setup did not implicate that the performance of the lot was negatively impacted.No false non-reactive results were obtained.A manufacturing documentation for the reagent lot was reviewed and did not identify any issues.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation no product deficiency was identified for the architect anti-hbc ii , lot number 07400be00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBC II
Type of Device
ANTI-HBC
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9793697
MDR Text Key193065067
Report Number3002809144-2020-00169
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/08/2020
Device Catalogue Number08L44-25
Device Lot Number07400BE00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/12/2020
Initial Date FDA Received03/05/2020
Supplement Dates Manufacturer Received03/30/2020
Supplement Dates FDA Received04/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LN 03M74-01, SERIAL (B)(4).; LN 03M74-01, SERIAL (B)(4).
Patient Age72 YR
-
-